Prognosis and complete remission rate of diffuse large B‐cell lymphoma patients in standard R‐CHOP with reduction of vincristine: A retrospective study

Background and Aims The effect of stopping or reducing the dose of vincristine in diffuse large B‐cell lymphoma (DLBCL) on the outcome and prognosis of the disease is still in doubt. The present study aimed to investigate and compare the prognosis and complete remission of two R‐CHOP treatment regim...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Health science reports Jg. 6; H. 12; S. e1716 - n/a
Hauptverfasser:	Riasi, Fatemeh, Ataei Azimi, Sajjad, Allahyari, Abolghasem, Moeini Nodeh, Mohammad, Shakeri, Mohammad T., Kamandi, Mostafa
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States John Wiley & Sons, Inc 01.12.2023 John Wiley and Sons Inc Wiley
Schlagworte:	Age Chemotherapy Dehydrogenases DLBCL Drug dosages Hematology Lymphoma Medical prognosis Medical records Original Research Peripheral neuropathy prognosis Radiation Remission (Medicine) R‐CHOP Survival analysis Toxicity vincristine DLBCL R‐CHOP vincristine prognosis
ISSN:	2398-8835, 2398-8835
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!